About this trial
The purpose of this study is to assess how accurately FedHist, an artificial intelligence model, predicts the risk of death in critically ill patients. Patients in intensive care units (ICUs) can become worse quickly. Updating risk estimates as new clinical information becomes available may help identify patients at higher risk. FedHist uses routinely collected clinical information to estimate a patient's risk of dying in the ICU within the next 24 hours. These estimates are updated every 6 hours.
This study will evaluate FedHist prospectively across several hospitals. The model will be integrated into hospital clinical information systems, and its predictions will be compared with observed patient outcomes. The study aims to determine whether FedHist provides accurate predictions across hospitals with different patient populations and clinical practices.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Admission to a participating ICU
Disqualifiers
Age younger than 18 years.
Expected ICU length of stay shorter than 24 hours.
Refusal to provide written informed consent.
Trial population
All patients admitted to the participating ICU
Trial design
Cohort
Prospective
Treatments tested in this trial
Risk of mortality
Other interventionPatients admitted to the ICU with different risk of mortality
Treatment groups
Trial outcomes
Primary outcomes
ICU mortality
The proportion of patients who die from any cause during the ICU stay, with follow-up capped at 90 days after ICU admission. For patients whose ICU stay exceeds 90 days, vital status at day 90 will be used to determine the mortality outcome.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: